| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/29/2009 | US20090029957 8-beta-substituted estratrienes as selectively active estrogens |
| 01/29/2009 | US20090029951 Antihypoxia agent; monocalcium tetrasodium salt of inositol tripyrophosphate; cancer, Alzheimer's |
| 01/29/2009 | US20090029940 Plymorphic form of inulin and uses thereof |
| 01/29/2009 | US20090029932 Identification and use of miRNAs for differentiating myeloid leukemia cells |
| 01/29/2009 | US20090029929 Decoy Nucleic Acid to Synoviolin Gene Promoter |
| 01/29/2009 | US20090029925 Interaction of bim with trim2, an e3 ubiquitin ligase |
| 01/29/2009 | US20090029458 Chicken leukemia inhibitory factor (LIF) and gene thereof |
| 01/29/2009 | US20090029457 Pharmaceutical composition for inducing an immune response in a human or animal |
| 01/29/2009 | US20090029444 Novel recombinant anticoagulant proteins |
| 01/29/2009 | US20090029400 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/29/2009 | US20090029380 HUMAN MutY |
| 01/29/2009 | US20090029361 Growth differentiation factor-7 |
| 01/29/2009 | US20090028972 Treating Neoplasms With Neurotoxin |
| 01/29/2009 | US20090028963 Polyphenol Coxib Combinations and Methods |
| 01/29/2009 | US20090028952 Hydroxy sulfonate of quinone compounds and their uses |
| 01/29/2009 | US20090028951 Compositions for Oral Administration of Sustained Release Glutathione, Methods for Their Production and Uses Thereof |
| 01/29/2009 | US20090028933 Compositions and methods for treating lymphoma |
| 01/29/2009 | US20090028931 Liposomal compositions for parenteral delivery of agents |
| 01/29/2009 | US20090028904 Novel cochleate formulations |
| 01/29/2009 | US20090028886 Carrier conjugates of gnrh-peptides |
| 01/29/2009 | US20090028883 Novel P-selectin Ligand Protein |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | US20090028878 Novel methods of cancer diagnosis and therapy targeted against a cancer stem line |
| 01/29/2009 | US20090028877 Antibody Composition Specifically Binding to Ganglioside Gm |
| 01/29/2009 | US20090028870 Treatment of Hematologic Disorders |
| 01/29/2009 | US20090028868 Anti-cancer pharmaceutical compositions and methods for treating patients with cancer |
| 01/29/2009 | US20090028867 Antagonists Specific For Denatured Collagen And Methods Of Using Same |
| 01/29/2009 | US20090028865 Method of treating hepatocellular carcinoma |
| 01/29/2009 | US20090028862 Emmprin antagonists and uses thereof |
| 01/29/2009 | US20090028861 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 01/29/2009 | US20090028859 Bispecific antibodies that bind to vegf receptors |
| 01/29/2009 | US20090028858 Substituted quinoline derivatives |
| 01/29/2009 | US20090028857 Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof |
| 01/29/2009 | US20090028855 Inhibitors of akt/pkb with anti-tumor activity |
| 01/29/2009 | US20090028852 Roles For Dual Endothelin-1/Angiotensin II Receptor (DEAR) In Hypertension and Angiogenesis |
| 01/29/2009 | US20090028851 Novel Antibodies Directed to the Mammalian Eag1 Ion Channel Protein |
| 01/29/2009 | US20090028847 Multiple myeloma and al amyloid immunotherapy targeting immunoglobulin light chains and uses thereof |
| 01/29/2009 | US20090028835 Human transcriptome corresponding to human oocytes and use of said genes or the corresponding polypeptides to trans-differentiate somatic cells |
| 01/29/2009 | US20090028832 Compositions and methods for targeted tumor therapy |
| 01/29/2009 | US20090028823 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases |
| 01/29/2009 | US20090028822 Glycopegylated Interferon Alpha |
| 01/29/2009 | US20090028821 Prodrugs of cc-a1065 analogs |
| 01/29/2009 | US20090028815 Diazabenzo[De]anthracen-3-one Compounds and Methods for Inhibiting Parp |
| 01/29/2009 | US20090028795 NOD1 as an Anti-Tumor Agent |
| 01/29/2009 | US20090028791 Dichloroacetate Analogs as Imaging Agents |
| 01/29/2009 | US20090028788 Compounds having rd targeting motifs |
| 01/29/2009 | US20090028784 Antibodies to IL-6 and use thereof |
| 01/29/2009 | CA2698271A1 Multikinase inhibitors for use in the treatment of cancer |
| 01/29/2009 | CA2694582A1 New compositions based on polysaccharides grafted by polyamine or polysulphurised compounds |
| 01/29/2009 | CA2694396A1 Targeted binding agents directed to kdr and uses thereof - 035 |
| 01/29/2009 | CA2694275A1 Organic compounds |
| 01/29/2009 | CA2694267A1 Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma |
| 01/29/2009 | CA2694216A1 Benzimidazole derivative |
| 01/29/2009 | CA2693901A1 Substituted indazole derivatives active as kinase inhibitors |
| 01/29/2009 | CA2693799A1 Use of imidazoquinolines for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
| 01/29/2009 | CA2691218A1 An antigen associated with lung cancers and lymphomas |
| 01/28/2009 | EP2019138A1 Method of constructing gene transport support |
| 01/28/2009 | EP2019122A1 Polymer conjugate of podophyllotoxin |
| 01/28/2009 | EP2019118A1 Method for synthesizing thymosins |
| 01/28/2009 | EP2019098A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor |
| 01/28/2009 | EP2018875A1 Poorly-water-soluble pharmaceutical agent |
| 01/28/2009 | EP2018873A1 Prophylactic/therapeutic agent for cancer |
| 01/28/2009 | EP2018869A1 Licorice polyphenol preparation |
| 01/28/2009 | EP2018865A2 Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an lhrh analogue and/or a bisphosphonate |
| 01/28/2009 | EP2018858A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic trioxide |
| 01/28/2009 | EP2018383A1 Triazolopyrazine derivatives useful as anti-cancer agents |
| 01/28/2009 | EP2018370A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors |
| 01/28/2009 | EP2018173A1 Magnetorheological fluids and therapeutic uses thereof |
| 01/28/2009 | EP2018170A2 Medication against breast cancer and related diseases |
| 01/28/2009 | EP2018167A2 Compositions and methods for fgf receptor kinases inhibitors |
| 01/28/2009 | EP1608664B1 Non-cross-linking pyrrolo[2,1-c][1,4]benzodiazepines as potential antitumour agents and process thereof |
| 01/28/2009 | EP1541672B1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/28/2009 | EP1207755B1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 01/28/2009 | EP1177181B1 Substituted bicyclic compounds |
| 01/28/2009 | CN101356195A Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 |
| 01/28/2009 | CN101356173A Novel pyridopyrazines and their use as modulators of kinases |
| 01/28/2009 | CN101356172A 激酶抑制剂 Kinase inhibitors |
| 01/28/2009 | CN101355969A Antiproliferative combination comprising CYC-682 and a cytotoxic agent |
| 01/28/2009 | CN101355945A Combination of ZD6474 and pemetrexed |
| 01/28/2009 | CN101355936A Combinations comprising a CDK inhibitor and a growth factor antibody or anti-mitotic |
| 01/28/2009 | CN101355934A Transcription set modifier and application of chemotherapeutics or actinotheraphy against cancer |
| 01/28/2009 | CN101353678A Fermentation substrate of antineoplastic compound deacetylase fungal epoxy ethyl ester |
| 01/28/2009 | CN101353656A siRNA inhibiting expression of epidermal growth factor receptor genes and use thereof |
| 01/28/2009 | CN101353655A siRNA inhibiting expression of vascular endothelial growth factor receptor genes and use thereof |
| 01/28/2009 | CN101353647A Simulating retrovirus of target tumor, and preparation and use thereof |
| 01/28/2009 | CN101353645A Granulocyte-macrophage colony stimulating factor gene modified allogene tumour cell vaccine |
| 01/28/2009 | CN101353368A Pregna medicament for treating tumor |
| 01/28/2009 | CN101353366A Steroidal estrogen medicament for treating tumor |
| 01/28/2009 | CN101353361A Preparation of adriablastina prodrug and use thereof |
| 01/28/2009 | CN101353357A Organo-tin compound, preparation and use thereof |
| 01/28/2009 | CN101353339A Synthesis of quercetin platinum |
| 01/28/2009 | CN101353334A Method for preparing docetaxel |
| 01/28/2009 | CN101353333A 10- deacetylate-9(R)-hydrogenization-1-deoxypaclitaxel analogue and preparation thereof |
| 01/28/2009 | CN101353296A Method for preparing (Z)-3í»-hydroxy-3,4,4í»,5-tetramethoxy diphenyl ethylene from regenerative natural plant resource |
| 01/28/2009 | CN101353294A Separation and purification method of high-content resveratrol |
| 01/28/2009 | CN101352574A Target polypeptide-gold/silicon dioxide nano complex particle and synthesis thereof |
| 01/28/2009 | CN101352572A Method for preparing folacin-carboxyl complexes |
| 01/28/2009 | CN101352561A Chinese medicinal composition for treating nasopharyngeal carcinoma and preparation method thereof |
| 01/28/2009 | CN101352560A Medicament for treating tumor |
| 01/28/2009 | CN101352559A Medicinal preparation for treating tumer |